Steven Loch is currently the President of Sage Biopharm Advisors LLC and is in an exclusive Strategic Partnership with The Griff Group.  Steven has over 25 years of Industry experience serving in positions of increasing responsibility in Managed Markets, National Accounts, Sales Management, Marketing, and Field Sales.

Steven is a highly accomplished, results-oriented Managed Markets Executive with extensive experience developing strategies and tactics to ensure access to and reimbursement for diverse biopharmaceutical product portfolios. Steven demonstrates an outstanding ability to devise and execute targeted account development and product launch strategies that ensure seamless and transparent reimbursement and optimal patient and markets access for both Traditional and Specialty Biopharmaceutical Products.

In addition Steven has a proven track record for the development and implementation of targeted strategies and tactics that ensure positive and profitable access/coverage across all Payor environments: Commercial MCOs & PBMs, Government (Medicare parts D & B, and Medicaid), Specialty Pharmacy Accounts, Hospital/Integrated Delivery Systems, and the Correctional Healthcare Markets.

Steven’s core competencies include: Motivational Leadership, Specialty/Biotech Product Expertise, Pricing/Reimbursement/Access Strategies, Business/Sales Strategy Development, Account Penetration/Management, Contract/Rebate Negotiation, Market Share/Revenue Growth, Formulary Access Strategy Creation, and Optimized Product Distribution Models.

Steven graduated Magna Cum Laude from California Lutheran University in Thousand Oaks, CA.